Literature DB >> 22634976

Epidemiologic aspects of abnormal ankle brachial index in the HIV infected population.

A Y Qaqa1, V A Debari, K El-Kersh, K Elkersh, R Sison, A Isbitan, N Mohammad, J Slim, G Perez, F E Shamoon.   

Abstract

AIM: HIV infection is strongly associated with accelerated vascular atherosclerosis and increased cardiovascular events. The prevalence of peripheral arterial disease (PAD) in HIV infected patients is not clearly defined and the results of different reports are contradicting.
OBJECTIVE: To determine the prevalence of abnormal Ankle Brachial Index (ABI) and associated risk factors in HIV infected population.
METHODS: The ABI was measured manually using 5.0 MHz handheld Doppler probe in 173 HIV infected patients. The cohort was categorized according to the ABI measurements as; normal group (ABI 0.9 to 1.3), peripheral arterial disease (PAD) group (ABI<0.9), and High ABI group (ABI>1.3). Several demographic, atherosclerosis risk factors and HIV infection parameters have been evaluated as potential risk factors.
RESULTS: Median age of the cohort was 49 years (inter-quartile ranges [IQR]: 42.5 to 54); 63.4% were males. Abnormal ABI was found in 47(27.2%) patients; twenty four (13.9%) had PAD and 23(13.3%) had high ABI. Among the risk factors evaluated, we observed that PAD group is associated with diabetes (Relative risk [RR]: 4.19; 95% confidence interval [CL]: 2.13 to 8.27; P=0.0002) and age above 49 (Relative risk [RR]: 3.96; 95% confidence interval [CL]: 1.56 to 10.0; P=0.002). However, the High ABI group was significantly associated with male gender (RR: 3.94; 95% CI: 1.23 to 12.70; P=0.009).
CONCLUSION: HIV infection is associated with increased prevalence of abnormal resting ABI.

Entities:  

Mesh:

Year:  2012        PMID: 22634976

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  4 in total

1.  Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population.

Authors:  Alexandra E Teng; Kevin F Kennedy; Rushi V Parikh; Ehrin J Armstrong; Priscilla Y Hsue; Eric A Secemsky
Journal:  AIDS       Date:  2022-07-15       Impact factor: 4.632

Review 2.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: a cross-sectional hospital-based study.

Authors:  Félicité Kamdem; Yacouba Mapoure; Ba Hamadou; Fanny Souksouna; Marie Solange Doualla; Ahmadou Musa Jingi; Caroline Kenmegne; Fernando Kemta Lekpa; Jaff Kweban Fenkeu; Gisèle Imandy; Jean Pierre Nda Mefo'o; Henry Luma
Journal:  Vasc Health Risk Manag       Date:  2018-12-06

Review 4.  What happens to cardiovascular system behind the undetectable level of HIV viremia?

Authors:  Gabriella d'Ettorre; Giancarlo Ceccarelli; Paolo Pavone; Pietro Vittozzi; Gabriella De Girolamo; Ivan Schietroma; Sara Serafino; Noemi Giustini; Vincenzo Vullo
Journal:  AIDS Res Ther       Date:  2016-04-27       Impact factor: 2.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.